Sazze — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Airbility is a South Korean aircraft developer working on high-speed electric vertical take-off and landing vehicles.
Mobility & Transportation
Jinmo LeeinMinyoung Ahn(Founder)in
Co-investors500 GlobalIndustrial Bank of KoreaPrimer Sazze PartnersStonebridge Ventures
Nitra provides a card, lending, and back-office platform built specifically for independent medical practices including ophthalmology, dental, aesthetics, and fertility clinics.
Enterprise SoftwareFintechHealthtechNew York, US
Tim Hwang(CEO)in
Co-investorsAAF Management Ltd.AppWorks VenturesDunamu & PartnersExpaFoundersXFoundersX Ventures+26 more
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.
BiotechDeep TechHealthtechSan Francisco, US
Laura Hsieh(Founder & CEO)in
Co-investorsFREEFLOWSOSVBrightEdgeEmpath VenturesStoryHouseXEIA Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











